Restructuring and
separation costs - - 646 -
Total operating
expenses 8,591 10,142 23,614 30,586
Loss from operations (8,591) (10,142) (23,614) (30,586)
Interest and other income,
net 480 844 1,471 2,526
Net loss $(8,111) $(9,298) $(22,143) $(28,060)
Net loss per share: basic and
diluted $(0.15) $(0.14) $(0.40) $(0.43)
Weighted average shares
outstanding:
basic and diluted 55,196,369 66,042,023 55,126,488 64,627,285
ALLOS THERAPEUTICS, INC.
CONDENSED BALANCE SHEETS
(in thousands)
(unaudited)
December 31, September 30,
2006 2007
ASSETS
Cash, cash equivalents and
investments in marketable
securities $32,796 $63,370
Other assets 2,982 3,525
Property and equipment, net 604 543
Total assets $36,382 $67,438
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities $6,832 $8,170
Stockholders' equity 29,550 59,268
Total liabilities and
stockholders' equity $36,382 $67,438
| SOURCE Allos Therapeutics, Inc. Copyright©2007 PR Newswire. All rights reserved |